Ann Dermatol.  2014 Oct;26(5):669-670. 10.5021/ad.2014.26.5.669.

Injection-Site Reaction Following 5-Azacitidine Injection

Affiliations
  • 1Department of Dermatology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea. frank@catholic.ac.kr

Abstract

No abstract available.


Figure

  • Fig. 1 An ecchymotic erythematous patch with bulla is visible on the abdomen where the 5-azacitidine was injected.


Reference

1. Keating GM. Azacitidine: a review of its use in higher-risk myelodysplastic syndromes/acute myeloid leukaemia. Drugs. 2009; 69:2501–2518.
2. Santini V, Fenaux P, Mufti GJ, Hellström-Lindberg E, Silverman LR, List A, et al. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine. Eur J Haematol. 2010; 85:130–138.
Article
3. Guarneri C, Polimeni G. Nicolau syndrome following etanercept administration. Am J Clin Dermatol. 2010; 11:Suppl 1. 51–52.
Article
4. Faucher L, Marcoux D. What syndrome is this? Nicolau syndrome. Pediatr Dermatol. 1995; 12:187–190.
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr